Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of InspireMD, Inc. (NYSEMKT:NSPR). The investigation concerns possible violations of federal securities laws, and focuses on the Company’s operations and financial prospects. InspireMD Inc. (NYSEMKT:NSPR) shares after opening at $2.25 moved to $2.25 on last trade day and at the end of the day closed at $2.10. Company price to sales ratio in past twelve months was calculated as 12.43 and price to cash ratio as 6.43. InspireMD Inc. (NYSEMKT:NSPR) showed a negative weekly performance of -12.50%.
USMD Holdings Inc. (NASDAQ:USMD) a physician-led integrated health system headquartered in Irving, has acquired the assets of Associates in Urology, a Fort Worth-based urology practice group, for an undisclosed amount. As a result of the acquisition, Dr. John Pumphrey and Dr. Michael Walter will join USMD’s physician group, bringing the total number of USMD urologists to 57. USMD Holdings Inc. (NASDAQ:USMD) shares fell -2.70% in last trading session and ended the day on $12.60. USMD return on equity ratio is recorded as 0.50% and its return on assets is 0.30%. USMD Holdings Inc. (NASDAQ:USMD) yearly performance is -1.18%.
PAREXEL International Corp. (NASDAQ:PRXL) Tuesday reported third-quarter net income of $34.7 million or $0.60 per share, up from $29.5 million or $0.50 per share in the same period last year. PAREXEL International Corporation (NASDAQ:PRXL) shares moved down -0.29% in last trading session and was closed at $45.35, while trading in range of $41.79 – $48.59. PAREXEL International Corporation (NASDAQ:PRXL) year to date (YTD) performance is 0.38%.
ICON plc logo ICON plc (NASDAQ:ICLR) posted its quarterly earnings results on Wednesday. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07, AnalystRatingsNetwork reports. ICON PLC (NASDAQ:ICLR) weekly performance is -11.63%. On last trading day company shares ended up $38.77. ICON PLC (NASDAQ:ICLR) distance from 50-day simple moving average (SMA50) is -15.46%. Analysts mean target price for the company is $53.60.